![Kathleen M. Hunter-Gregory](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kathleen M. Hunter-Gregory
Treasurer chez Sertoli Technologies LLC
Postes actifs de Kathleen M. Hunter-Gregory
Sociétés | Poste | Début | Fin |
---|---|---|---|
Sertoli Technologies LLC
![]() Sertoli Technologies LLC Medical/Nursing ServicesHealth Services Sertoli Technologies, Inc. provides medical services. It develops products to treat insulin-dependent diabetes and hemophilia. The company technology enables treatment of life-threatening diseases caused by a patient's impaired ability to produce a protein, such as insulin in diabetes or factor XIII in hemophilia. Sertoli Technologies was founded in 1996 and is headquartered in Tucson, AZ. | Treasurer | 15/02/2010 | - |
Historique de carrière de Kathleen M. Hunter-Gregory
Anciens postes connus de Kathleen M. Hunter-Gregory
Sociétés | Poste | Début | Fin |
---|---|---|---|
RCT BioVentures
![]() RCT BioVentures Investment ManagersFinance RCT BioVentures (RCT BioVentures) is a venture capital subsidiary of Research Corporation Technologies Inc founded in 1987. The firm is headquartered in Tucson, Arizona. | Comptroller/Controller/Auditor | 01/01/1992 | - |
Formation de Kathleen M. Hunter-Gregory
University of Arizona | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Comptroller/Controller/Auditor | 1 |
Treasurer | 1 |
Undergraduate Degree | 1 |
Sectorielle
Finance | 2 |
Health Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
RCT BioVentures
![]() RCT BioVentures Investment ManagersFinance RCT BioVentures (RCT BioVentures) is a venture capital subsidiary of Research Corporation Technologies Inc founded in 1987. The firm is headquartered in Tucson, Arizona. | Finance |
Sertoli Technologies LLC
![]() Sertoli Technologies LLC Medical/Nursing ServicesHealth Services Sertoli Technologies, Inc. provides medical services. It develops products to treat insulin-dependent diabetes and hemophilia. The company technology enables treatment of life-threatening diseases caused by a patient's impaired ability to produce a protein, such as insulin in diabetes or factor XIII in hemophilia. Sertoli Technologies was founded in 1996 and is headquartered in Tucson, AZ. | Health Services |
- Bourse
- Insiders
- Kathleen M. Hunter-Gregory
- Expérience